Abaxis Inc (ABAX) Return on Equity ROE from the fourth quarter 2018 to fourth quarter 2017 and annually, average high and low, overall ranking from Mar 31 2018 to Mar 31 2017 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Abaxis Inc  (ABAX)

Abaxis Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Abaxis Inc in the fourth quarter 2018?
Abaxis Inc achieved a return on average equity (ROE) of 9.52 % in its fourth quarter 2018, which is below Abaxis Inc's average return on equity, which stands at 11.99%.

ROE has advanced compared to 9.02% in the third quarter 2018, due to net income growth.

Within the Laboratory Analytical Instruments industry 5 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2018 from 1553 to 1637.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2018)
IV. Quarter		 (Dec 31 2017)
III. Quarter		 (Sep 30 2017)
II. Quarter		 (Jun 30 2017)
II. Quarter		 (Mar 31 2017)
IV. Quarter
Y / Y Equity Change 9.19 % 8.45 % 9.47 % 11.97 % -
Y / Y Net Income Change 25.91 % -38.25 % -42.26 % -8.13 % -14.8 %
Net Income (TTM) in Millions 27 25 27 32 33
Return On Equity (TTM) 9.52 % 9.02 % 10.18 % 12.25 % 12.82 %
ABAX's Total Ranking # 1637 # 1553 # 951 # 1029 #
Equity (TTM) in Millions 291 281 277 271 266
Seq. Equity Change 3.43 % 1.43 % 2.19 % 1.85 % 2.73 %
Seq. Net Income Change 124.94 % -35.98 % 4.28 % -16.16 % 10.32 %

Back to ABAX Management Effectiveness >> ABAX's 5 Years Annual ROE >> Compare ABAX ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 6
Sector # 107
Overall # 1637

Return On Equity Statistics
High Average Low
16.03 %
11.99 %
7.62 %
(Mar 31 2013)   (Mar 31 2014)





ABAX Annual Return On Equity (Mar 31 2018)
2018		 (Mar 31 2017)
2017		 (Mar 31 2016)
2016		 (Mar 31 2015)
2015		 (Mar 31 2014)
2014
Total Equity in Millions 291 266 236 220 194
Y / Y Equity Change 9.19 % 12.66 % 7.32 % 13.55 % 10.06 %
Net Income in Millions 27 33 32 27 14
Y / Y Net Income Change -16.93 % 3.43 % 15.73 % 92.68 % -48.34 %
Return On Equity 9.35 % 12.29 % 13.38 % 12.41 % 7.32 %

Back to ABAX Management Effectiveness >> ABAX's 5 Years Annual ROE >> Compare ABAX ROE to its Competitors




Annual Roe Comment
In 2018 ROE decreased compared to the previous year to 9.35 %, due to deterioration of net income.


More Return On Equity Ratios
Laboratory Analytical Instruments Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ABAX's' Return on Equity at Yahoo Finance
ABAX's Roe Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ABAX's Competitors
Subscribers only: Roe for Abaxis Inc's Suppliers
Subscribers only: Return On Equity for ABAX's Customers




Companies with similar Return On Equity at Mar 31 2018, within Healthcare Sector ROE
Escalon Medical Corp   25.44 %
Encompass Health Corporation  25.09 %
Biogen Inc   24.24 %
Carlisle Companies Incorporated  24.15 %
Regenxbio Inc   23.88 %
Regeneron Pharmaceuticals Inc   23.51 %
Bio rad Laboratories Inc   23.29 %
United Therapeutics Corporation  23.27 %
Chemed Corporation  22.92 %
Align Technology inc   22.73 %
Cambrex Corp  20.25 %
Atrion Corporation  19.35 %
Labcorp Holdings Inc   18.85 %
Alpha Pro Tech Ltd   18.62 %
Illumina Inc   18.50 %
Edwards Lifesciences Corporation  18.21 %
Abiomed Inc   17.99 %
Eagle Pharmaceuticals inc   17.98 %
Lifevantage Corp  17.80 %
Jazz Pharmaceuticals Plc  17.59 %
Enanta Pharmaceuticals Inc  17.48 %
Biospecifics Technologies Corp  17.33 %
Pacific Health Care Organization Inc  17.22 %
Quest Diagnostics Inc  17.12 %
Healthcare Services Group Inc   16.99 %
Lemaitre Vascular Inc   16.66 %
Masimo Corp  16.30 %
Cantel Medical Corp   16.17 %
Iqvia Holdings Inc   15.74 %
Encision Inc   15.71 %

Date modified: 2026-07-06T17:55:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.